Pechstein B - Search Results

1

Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF.

Ludwig M, Albano C, Olivennes F, Felberbaum RE, Smitz J, Ortmann O, Romeis P, Niebch G, Pechstein B, Riethmüller-Winzen H, Devroey P, Diedrich K. Ludwig M, et al. Among authors: pechstein b. Arch Gynecol Obstet. 2002 Jan;266(1):12-7. doi: 10.1007/pl00007490. Arch Gynecol Obstet. 2002. PMID: 11998957

2

Pharmacokinetic-pharmacodynamic modeling of testosterone and luteinizing hormone suppression by cetrorelix in healthy volunteers.

Pechstein B, Nagaraja NV, Hermann R, Romeis P, Locher M, Derendorf H. Pechstein B, et al. J Clin Pharmacol. 2000 Mar;40(3):266-74. doi: 10.1177/00912700022008937. J Clin Pharmacol. 2000. PMID: 10709155 Clinical Trial.

3

Pharmacokinetic and pharmacodynamic modeling of cetrorelix, an LH-RH antagonist, after subcutaneous administration in healthy premenopausal women.

Nagaraja NV, Pechstein B, Erb K, Klipping C, Hermann R, Niebch G, Derendorf H. Nagaraja NV, et al. Among authors: pechstein b. Clin Pharmacol Ther. 2000 Dec;68(6):617-25. doi: 10.1067/mcp.2000.111481. Clin Pharmacol Ther. 2000. PMID: 11180022 Clinical Trial.

4

Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.

Erb K, Klipping C, Duijkers I, Pechstein B, Schueler A, Hermann R. Erb K, et al. Among authors: pechstein b. Fertil Steril. 2001 Feb;75(2):316-23. doi: 10.1016/s0015-0282(00)01702-7. Fertil Steril. 2001. PMID: 11172833 Free article. Clinical Trial.

5

Pituitary and gonadal endocrine effects and pharmacokinetics of the novel luteinizing hormone-releasing hormone antagonist teverelix in healthy men--a first-dose-in-humans study.

Erb K, Pechstein B, Schueler A, Engel J, Hermann R. Erb K, et al. Among authors: pechstein b. Clin Pharmacol Ther. 2000 Jun;67(6):660-9. doi: 10.1067/mcp.2000.106894. Clin Pharmacol Ther. 2000. PMID: 10872648 Clinical Trial.

6

Novel formulations of cetrorelix acetate in healthy men: pharmacodynamic effects and noncompartmental pharmacokinetics.

Erb K, Junge K, Pechstein B, Schneider E, Derendorf H, Hermann R. Erb K, et al. Among authors: pechstein b. J Clin Pharmacol. 2002 Sep;42(9):995-1001. J Clin Pharmacol. 2002. PMID: 12211225 Clinical Trial.

7

Pharmacokinetic/pharmacodynamic modeling of luteinizing hormone (LH) suppression and LH surge delay by cetrorelix after single and multiple doses in healthy premenopausal women.

Nagaraja NV, Pechstein B, Erb K, Klipping C, Hermann R, Locher M, Derendorf H. Nagaraja NV, et al. Among authors: pechstein b. J Clin Pharmacol. 2003 Mar;43(3):243-51. doi: 10.1177/0091270003251377. J Clin Pharmacol. 2003. PMID: 12638392 Clinical Trial.

8

Retigabine N-glucuronidation and its potential role in enterohepatic circulation.

Hiller A, Nguyen N, Strassburg CP, Li Q, Jainta H, Pechstein B, Ruus P, Engel J, Tukey RH, Kronbach T. Hiller A, et al. Among authors: pechstein b. Drug Metab Dispos. 1999 May;27(5):605-12. Drug Metab Dispos. 1999. PMID: 10220490

9

Determination of the two diastereoisomers of lobaplatin (D-19466) in plasma ultrafiltrate of cancer patients with a normal or an impaired kidney or liver function by high-performance liquid chromatography with ultraviolet detection.

Welink J, Pechstein B, van der Vijgh WJ. Welink J, et al. Among authors: pechstein b. J Chromatogr B Biomed Appl. 1996 Jan 12;675(1):107-11. doi: 10.1016/0378-4347(95)00353-3. J Chromatogr B Biomed Appl. 1996. PMID: 8634751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters